-
May 24, 2013
The US firm says its future will be focused on its pharmaceuticals unit in order to help it stay within the top ten biggest pharma companies
-
May 23, 2013
Merck & Co discontinues development of Parkinson's candidate
-
May 24, 2013
Healthcare organisations expanding into emerging markets like Brazil, Russia, India and China (BRIC) are now realising that there are no shortcuts, and they need to be changing the dialogue around these nations, a new report has advised.
-
May 23, 2013
Irish drugmaker Elan has once again spurned the advances on Royalty Pharma, despite the latter having upped its bid to $12.50 a share, or around $6.4 billion.
-
May 23, 2013
A panel of experts at the US Food and Drug Administration has recommended Merck & Co's insomnia drug suvorexant when given in lower dosages but rejected the higher dose that the company was seeking
-
May 23, 2013
As Ranbaxy laid out some of the actions it has taken "to address certain conduct of the past" to ensure the safety of its products, reports are circulating that the Indian drugmaker could shed up to a third of its salesforce
-
May 22, 2013
GlaxoSmithKline has entered into a deal with the US government to develop drugs to fight antibiotic resistance and bioterrorism
-
May 22, 2013
Pfizer has announced plans to wind down its interest in animal health group Zoetis in order to focus on its core biopharmaceuticals business.
-
May 23, 2013
Boehringer Ingelheim says it will act promptly to resolve a series of manufacturing complaints highlighted by regulators in the USA concerning violations at its German headquarters
-
May 22, 2013
The long-standing alliance between Sanofi and Regeneron looks to have scored another clinical goal, this time with dupilumab for asthma